Summary by Moomoo AI
James Patrick Kelly, the Executive Vice President, Chief Financial Officer, and Treasurer of Novavax, Inc. (NVAX), has executed a transaction involving the company's stock. The action took place on March 1, 2024. However, the announcement did not disclose the number of shares transacted, the nature of the shares, the transaction price, or the total value of the shares. Additionally, the number of shares held by Kelly after the transaction was not provided. This information is typically crucial for investors to assess the implications of insider transactions on their investment decisions.